HopeStage
Back to all studies
TerminatedNCT01504659

Intranasal Ketamine In the Treatment of Pediatric Bipolarity

Medication studyAges 6–12United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 6 years to 12 years.

Listed locations
Not Predetermined and 3 more locationsSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJuly 2012
Recruitment status
Terminated
Enrollment listed in the registry
5
Sponsor
Juvenile Bipolar Research Foundation
Sponsor type
Non-profit organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 6 Years to 12 Years
Official registry ID
NCT01504659
Official title
Show the full official title

Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder

Recruitment & locations

Terminated

Not Predetermined · Maplewood

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Juvenile Bipolar Research Foundation.

Does this study involve medication?

Yes. The study involves medication, including Ketamine hydrochloride injection and Flat tonic water (e.g., Canada Dry Tonic Water).

Who can participate?

Listed age limits: 6 years to 12 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies